These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 22002347)
1. BK virus-specific T cells for use in cellular therapy show specificity to multiple antigens and polyfunctional cytokine responses. Blyth E; Clancy L; Simms R; Gaundar S; O'Connell P; Micklethwaite K; Gottlieb DJ Transplantation; 2011 Nov; 92(10):1077-84. PubMed ID: 22002347 [TBL] [Abstract][Full Text] [Related]
2. Novel approach for improved assessment of phenotypic and functional characteristics of BKV-specific T-cell immunity. Trydzenskaya H; Sattler A; Müller K; Schachtner T; Dang-Heine C; Friedrich P; Nickel P; Hoerstrup J; Schindler R; Thiel A; Melzig MF; Reinke P; Babel N Transplantation; 2011 Dec; 92(11):1269-77. PubMed ID: 22124284 [TBL] [Abstract][Full Text] [Related]
3. Functional characterization of BK virus-specific CD4+ T cells with cytotoxic potential in seropositive adults. Zhou W; Sharma M; Martinez J; Srivastava T; Diamond DJ; Knowles W; Lacey SF Viral Immunol; 2007 Sep; 20(3):379-88. PubMed ID: 17931108 [TBL] [Abstract][Full Text] [Related]
4. CD4+ T Cell Immune Response to VP1 and VP3 in BK Virus Infected Recipients of Renal Transplantation. Fan Y; Bai H; Qian Y; Sun Z; Shi B Surg Infect (Larchmt); 2019 Apr; 20(3):236-243. PubMed ID: 30707648 [TBL] [Abstract][Full Text] [Related]
5. Detection of CD8+ T cells sensitized to BK virus large T antigen in healthy volunteers and kidney transplant recipients. Randhawa PS; Popescu I; Macedo C; Zeevi A; Shapiro R; Vats AN; Metes D Hum Immunol; 2006; 67(4-5):298-302. PubMed ID: 16720209 [TBL] [Abstract][Full Text] [Related]
6. Antigenic competition in the generation of multi-virus-specific cell lines for immunotherapy of human cytomegalovirus, polyomavirus BK, Epstein-Barr virus and adenovirus infection in haematopoietic stem cell transplant recipients. Roubalová K; Němečková Š; Kryštofová J; Hainz P; Pumannová M; Hamšíková E Immunol Lett; 2020 Dec; 228():64-69. PubMed ID: 33031870 [TBL] [Abstract][Full Text] [Related]
7. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy. Chen Y; Trofe J; Gordon J; Du Pasquier RA; Roy-Chaudhury P; Kuroda MJ; Woodle ES; Khalili K; Koralnik IJ J Virol; 2006 Apr; 80(7):3495-505. PubMed ID: 16537617 [TBL] [Abstract][Full Text] [Related]
8. Unique BK virus non-coding control region (NCCR) variants in hematopoietic stem cell transplant recipients with and without hemorrhagic cystitis. Carr MJ; McCormack GP; Mutton KJ; Crowley B J Med Virol; 2006 Apr; 78(4):485-93. PubMed ID: 16482558 [TBL] [Abstract][Full Text] [Related]
9. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens. Karlsson H; Brewin J; Kinnon C; Veys P; Amrolia PJ J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295 [TBL] [Abstract][Full Text] [Related]
10. BK-VP3 as a new target of cellular immunity in BK virus infection. Mueller K; Schachtner T; Sattler A; Meier S; Friedrich P; Trydzenskaya H; Hinrichs C; Trappe R; Thiel A; Reinke P; Babel N Transplantation; 2011 Jan; 91(1):100-7. PubMed ID: 21452414 [TBL] [Abstract][Full Text] [Related]
11. Cross-reactivity of T lymphocytes recognizing a human cytotoxic T-lymphocyte epitope within BK and JC virus VP1 polypeptides. Krymskaya L; Sharma MC; Martinez J; Haq W; Huang EC; Limaye AP; Diamond DJ; Lacey SF J Virol; 2005 Sep; 79(17):11170-8. PubMed ID: 16103168 [TBL] [Abstract][Full Text] [Related]
13. Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-cell lines in seropositive healthy individuals and renal transplant recipients. Comoli P; Basso S; Azzi A; Moretta A; De Santis R; Del Galdo F; De Palma R; Valente U; Nocera A; Perfumo F; Locatelli F; Maccario R; Ginevri F J Am Soc Nephrol; 2003 Dec; 14(12):3197-204. PubMed ID: 14638918 [TBL] [Abstract][Full Text] [Related]
14. T-cell responses to peptide fragments of the BK virus T antigen: implications for cross-reactivity of immune response to JC virus. Li J; Melenhorst J; Hensel N; Rezvani K; Sconocchia G; Kilical Y; Hou J; Curfman B; Major E; Barrett AJ J Gen Virol; 2006 Oct; 87(Pt 10):2951-2960. PubMed ID: 16963754 [TBL] [Abstract][Full Text] [Related]
15. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes. Comoli P; Pedrazzoli P; Maccario R; Basso S; Carminati O; Labirio M; Schiavo R; Secondino S; Frasson C; Perotti C; Moroni M; Locatelli F; Siena S J Clin Oncol; 2005 Dec; 23(35):8942-9. PubMed ID: 16204009 [TBL] [Abstract][Full Text] [Related]
16. Virus specific antigens in BK virus-transformed cells detected by cell-mediated immune reactions. Karjalainen HE; Laaksonen AM; Mäntyjärvi RA Med Biol; 1983 Feb; 61(1):73-8. PubMed ID: 6302408 [TBL] [Abstract][Full Text] [Related]
17. Simultaneous isolation of CD8(+) and CD4(+) T cells specific for multiple viruses for broad antiviral immune reconstitution after allogeneic stem cell transplantation. Zandvliet ML; van Liempt E; Jedema I; Kruithof S; Kester MG; Guchelaar HJ; Falkenburg JH; Meij P J Immunother; 2011 Apr; 34(3):307-19. PubMed ID: 21389867 [TBL] [Abstract][Full Text] [Related]
18. Definition and characterization of novel HLA-*A02-restricted CD8+ T cell epitopes derived from JCV polyomavirus with clinical relevance. Mani J; Wang L; Hückelhoven AG; Schmitt A; Gedvilaite A; Jin N; Kleist C; Ho AD; Schmitt M Oncotarget; 2017 Jan; 8(2):2485-2500. PubMed ID: 27705933 [TBL] [Abstract][Full Text] [Related]
19. Cross-reactive CTL recognizing two HLA-A*02-restricted epitopes within the BK virus and JC virus VP1 polypeptides are frequent in immunocompetent individuals. Sharma MC; Zhou W; Martinez J; Krymskaya L; Srivastava T; Haq W; Diamond DJ; Lacey SF Virology; 2006 Jun; 350(1):128-36. PubMed ID: 16600320 [TBL] [Abstract][Full Text] [Related]
20. Augmentation of virus-specific immunity after hematopoietic stem cell transplantation by adoptive T-cell therapy. Peggs KS; Mackinnon S Hum Immunol; 2004 May; 65(5):550-7. PubMed ID: 15172456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]